Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study

Healey, Jeff S; Oldgren, Jonas; Ezekowitz, Michael; Zhu, Jun; Pais, Prem; Wang, Jia; Commerford, Patrick; Jansky, Petr; Avezum, Alvaro; Sigamani, Alben; Demasceno, Albertino; Reilly, Paul; Grinvalds, Alex; Nakamya, Juliet; Aje, Akinyemi; Almahmeed, Wael; Moriarty, Andrew; Wallentin, Lars; Yusuf, Lars Salim; Connolly, Stuart J.
Lancet ; 388(10050): 1161-1169, 2016.
Artículo en Inglés | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1064592

Documentos relacionados

  1. Resource use and cost associated with computerized decision support system and usual care in managing patients with atrial fibrillation: analysis of IMPACT-AF randomized trial data.
  2. Recent advances in gene therapy for atrial fibrillation.
  3. Repeat ablation strategy for recurrent persistent atrial fibrillation: A propensity-matched score comparison between "2C3L" and "extensive ablation" approach.
  4. Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: a rapid evaluation of barriers and facilitators to care.
  5. Lipids and atrial fibrillation: New insights into a paradox.
  6. Does a nurse-led interventional program improve clinical outcomes in patients with atrial fibrillation? A meta-analysis.
  7. Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
  8. Effectiveness of single-lead ECG devices for detecting atrial fibrillation: An overview of systematic reviews.
  9. Predictors of ibrutinib-associated atrial fibrillation: 5-year follow-up of a prospective study.
  10. Atrial Fibrillation.